Sodium salt of 5-cyclopropyl-2-{[2-(2,6difluorophenyl)pyrimidin-5-yl]amino}benz oic acid as DHODH inhibitor

Details for Australian Patent Application No. 2010223526 (hide)

Owner Almirall, S.A.

Inventors Garcia Gonzalez, Nuria; Carrera Carrera, Francesc; Julia Jane, Montserrat; Debethune, Laurent; Serra Masia, Xavier

Agent Davies Collison Cave

Pub. Number AU-A-2010223526

PCT Pub. Number WO2010/102824

Priority 09382033.0 13.03.09 EP

Filing date 11 March 2010

Wipo publication date 16 September 2010

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/102824 Priority application(s): WO2010/102824

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010223527-Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

2010223524-Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against antigens in replication deficient recombinant virus vaccines